These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6198804)

  • 21. Suppression of the immune response by cytotoxic T cells.
    Simpson E
    Nature; 1988 Dec; 336(6198):426. PubMed ID: 2461516
    [No Abstract]   [Full Text] [Related]  

  • 22. [Radiotherapy and antitumor immunity. Fundamentals of immunooncology].
    Klimovich VB
    Med Radiol (Mosk); 1982 Jun; 27(6):68-73. PubMed ID: 6213829
    [No Abstract]   [Full Text] [Related]  

  • 23. [Large, granular lymphocytes, a new population of mononuclear blood cells].
    Gastl G; Niederwieser D; Huber C
    Wien Klin Wochenschr; 1983 Mar; 95(5):154-8. PubMed ID: 6602424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NKT cells and tumor immunity--a double-edged sword.
    Smyth MJ; Godfrey DI
    Nat Immunol; 2000 Dec; 1(6):459-60. PubMed ID: 11101862
    [No Abstract]   [Full Text] [Related]  

  • 25. Increased natural killer cells and decreased regulatory T cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
    Witkiewicz AK; McConnell T; Potoczek M; Emmons RV; Kurman RJ
    Hum Pathol; 2010 Jan; 41(1):26-32. PubMed ID: 19733383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunology of multiple sclerosis.
    Oger J; Roos R; Antel JP
    Neurol Clin; 1983 Aug; 1(3):655-79. PubMed ID: 6209537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Natural cytotoxic cells (NK cells)].
    Frydecka I
    Pol Tyg Lek; 1983 Oct 17-24; 38(42-43):1343-5. PubMed ID: 6371740
    [No Abstract]   [Full Text] [Related]  

  • 28. [Lymphocyte subpopulations in psoriatic arthritis].
    Schnabel I; Hein G
    Z Gesamte Inn Med; 1984 Nov; 39(21):539-40. PubMed ID: 6240838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How lymphocytes kill tumor and other cellular targets.
    DiNome MA; Young JD
    Hosp Pract (Off Ed); 1987 May; 22(5A):59-66. PubMed ID: 3108278
    [No Abstract]   [Full Text] [Related]  

  • 30. The distribution and possible significance of cells identified in human lymphoid tissue by the monoclonal antibody HNK-1.
    Ritchie AW; James K; Micklem HS
    Clin Exp Immunol; 1983 Mar; 51(3):439-47. PubMed ID: 6221840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diversity and pathology of lymphocytes].
    Govaerts A
    Rev Med Brux; 1982 Apr; 3(4):235-6. PubMed ID: 6211756
    [No Abstract]   [Full Text] [Related]  

  • 32. [The count of the large granule-containing lymphocytes of the peripheral blood and the natural killer activity in patients with malignant tumors].
    Kindzel'skiĭ LP; Zlochevskaia LL; Tsyganok TV; Shabaeva MM; Zhukova MM; Rudaia OI
    Vrach Delo; 1990 Aug; (8):31-2. PubMed ID: 2256279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preliminary evaluation of immunotherapy in patients with Hodgkin's disease.
    Zywicka-Lopaciuk H; Konopka L; Karpowicz M; Sylwestrowicz T; Maślanka K; Arczyńska-Brojer E; Cieśluk S; Małkowska-Zwierz W; Pawelski S
    Arch Immunol Ther Exp (Warsz); 1981; 29(6):739-55. PubMed ID: 7349093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effects of cyclosporin-A on lymphocyte subpopulations.
    Leapman SB; Filo RS; Smith EJ; Smith PG
    Transplant Proc; 1981 Mar; 13(1 Pt 1):405-9. PubMed ID: 6455796
    [No Abstract]   [Full Text] [Related]  

  • 35. [Immunity and hypersensitivity in Hodgkin's lymphoma].
    Leoni P; Marchegiani G; Montillo M; Centurioni R; Montroni M; Danieli G
    Minerva Med; 1982 May; 73(20):1361-9. PubMed ID: 6210855
    [No Abstract]   [Full Text] [Related]  

  • 36. Ganoderma lucidum polysaccharides enhance the function of immunological effector cells in immunosuppressed mice.
    Zhu XL; Chen AF; Lin ZB
    J Ethnopharmacol; 2007 May; 111(2):219-26. PubMed ID: 17182202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The natural killer cells].
    Bilynskiĭ BT; Shparik IaV
    Vopr Onkol; 1980; 26(7):95-104. PubMed ID: 6447405
    [No Abstract]   [Full Text] [Related]  

  • 38. Lymphocyte migration in malignant disease.
    Crowther D; Wagstaff J
    Clin Exp Immunol; 1983 Mar; 51(3):413-20. PubMed ID: 6342879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [New insights into cytotoxic effector cells].
    Rey J; Olive D; Sébahoun G; O'Callaghan T; Costello RT
    Bull Cancer; 2005 Nov; 92(11):935-43. PubMed ID: 16316827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immune response dynamics during malignant tumor development].
    Stepanova NV
    Biofizika; 1979; 24(5):897-902. PubMed ID: 158393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.